<DOC>
	<DOCNO>NCT00958711</DOCNO>
	<brief_summary>The purpose study ass mechanism action Unite Biomatrix compare performance standard care , saline moisten gauze , treatment diabetic foot ulcer .</brief_summary>
	<brief_title>The Mechanism Action Unite Biomatrix Diabetic Foot Ulcer</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>1 . A full thickness diabetic foot ulcer viable wound bed free necrotic material ( grade 1 Wagner scale ) . 2 . Diagnosis diabetes mellitus ( type I II ) adequately control . 3 . The ulcer great 4 week duration . 4 . Three few ulcer separate &gt; 3.0 cm distance . 5 . Postdebridement , ulcer size must 1 10 sq cm2 . 6 . Ankle/brachial index 0.7 1.2 one following must present : transcutaneous partial pressure oxygen ( TcPO2 ) &gt; 30 mmHg ankle toe pressure &gt; 40mm Hg Doppler waveform consistent adequate flow foot ( biphasic triphasic ) 7 . At least 18 year old . 8 . Able willing provide voluntary write informed consent . 9 . Able willing wear offload orthopedic shoe . 10 . Able willing attend schedule followup visit study related exam . 1 . Greater 30 % reduction wound size first week observation investigator . 2 . Ulcer expose tendon bone . 3 . Gross clinical infection study ulcer site include cellulitis osteomyelitis . 4 . Gangrene . 5 . Active Charcot 's disease determine clinical radiographic examination . 6 . Ulcer nondiabetic pathophysiology ( e.g. , rheumatoid , radiationrelated , vasculitis related ulcer ) . 7 . Known severe anemia . 8 . Known serum albumin &lt; 2.5 . 9 . Renal failure Creatinine &gt; 2.5 . 10 . Rheumatoid arthritis ( collagen vascular disease ) , vasculitis , sickle cell disease , HIV . 11 . Severe liver disease define treat physician patient 's primary care physician . 12 . Malignancy near ulcer site . 13 . Any condition judge investigator would cause study detrimental patient . 14 . Presence hematology , clinical , chemistry test obtain within 7 day screen outside normal range laboratory determine clinically significant investigator . 15 . Received another investigational device drug within 30 day Day 0 . 16 . Radiation therapy , chemotherapy immunosuppressive therapy within 30 day enrollment . 17 . Received another allograft , autograft xenograft within 30 day Day 0 . 18 . Known allergy equine derive tissue . 19 . Alcohol drug abuse , define current medical treatment substance abuse . 20 . Pregnant nursing woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>